MODIFIED STAGE-I (T1NOM0, T2NOM0), NONSMALL CELL LUNG-CANCER - TREATMENT RESULTS, RECURRENCE PATTERNS, AND ADJUVANT IMMUNOTHERAPY

被引：0
|
作者：
LITTLE, AG
DEMEESTER, TR
FERGUSON, MK
SKINNER, DB
HOFFMAN, PC
SKOSEY, C
BLOUGH, RR
GOLOMB, HM
机构：
[1] UNIV CHICAGO,CTR MED,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,CTR MED,BIOMED COMPUTAT FACILITIES,CHICAGO,IL 60637
来源：
SURGERY | 1986年 / 100卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：621 / 628
页数：8
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported?
    Speicher, Paul J.
    Gu, Lin
    Wang, Xiaofei
    Hartwig, Matthew G.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (06): : 755 - 761
  • [42] Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer
    Zhang, Tianxiang
    Guo, Qiang
    Zhang, Ye
    Liu, Zhidong
    Zhou, Shijie
    Xu, Shaofa
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (01) : 139 - 144
  • [43] Prognostic Value of Lymphovascular Invasion and Its Effect on Patterns of Recurrence in T1-3N0 Non-Small Cell Lung Cancer
    Kim, Y. S.
    Hong, J. H.
    Sung, S. Y.
    Kwak, Y.
    Lee, S.
    Park, J. K.
    Kim, K. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S832 - S832
  • [44] Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1-2 N0
    Tanaka, K
    Kubota, K
    Kodama, T
    Nagai, K
    Nishiwaki, Y
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1039 - 1042
  • [45] A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients
    Wang, Wei
    Zhou, Juying
    CANCER CONTROL, 2023, 30
  • [46] Comparison of survival between lobectomy and trisegmentectomy for clinical stage T1c-2aN0M0 non-small cell lung cancer in the left upper segment of the lung
    Nakagawa, Tatsuo
    Miyamoto, Ei
    Ohsumi, Yuki
    Gotoh, Masashi
    Matsuoka, Tomoaki
    Kobayashi, Masashi
    Omasa, Mitsugu
    Okumura, Norihito
    UPDATES IN SURGERY, 2024, : 523 - 532
  • [47] Expression of mutant p53 and VEGF in prognosis of the treatment results in patients with differentiated squamous cell lung cancer (DSCLC), T2N0M0
    Laktionov, KK
    Polotsky, BE
    Stepanova, EV
    Barishnikov, YA
    Davidov, MI
    Yudin, DI
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 418 - 418
  • [48] Commentary: Adjuvant therapy in resected T1 2N0 non-small cell lung cancer: Surgeons should lead
    Chudgar, Neel P.
    Stiles, Brendon M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (05): : 1693 - 1694
  • [49] Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis
    Ge, Tao
    Zhu, Shuncang
    Sun, Liangdong
    Yin, Laibo
    Dai, Jie
    Qian, Jiayi
    Chen, Xiangru
    Zhang, Peng
    Zhu, Jialong
    Jiang, Gening
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Comparison of survival results of patients with T0 and T1-2-3 in pathological T staging in patients with non-small cell lung cancer who underwent surgery after neoadjuvant treatment
    Kermenli, Tayfun
    Melek, Huseyin
    Bayram, Ahmet Sami
    Gebitekin, Cengiz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 17 (02) : 47 - 51
12345